
Keywords: Hereditary angioedema; Icatibant; Home-based treatment; Bradykinin-receptor antagonist; AE; Adverse event; HAE; Hereditary angioedema; HCP-administration; Administration by health care professionals at medical facilities; ISR; Injection-site reaction; PSS